1. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung carcinoma patients responding to atezolizumab treatment. (March 2019) Authors: Fehlings, M.; Nardin, A.; Jhunjhunwala, S.; Kowanetz, M.; O'Gorman, B.; Hegde, P.; Li, J.; Sumatoh, H.; Lee, B.; Kim, L.; Flynn, S.; Ballinger, M.; Newell, E.; Yadav, M. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗